Choose a format and confirm the details before payment.Formats

Metabolic signaling research

Retatrutide

Three metabolic targets, one peptide: GLP-1, GIP and glucagon in weight-regulation research.

Format10 mg
From1,700,000 VND ≈ $66
StatusConfirm before payment
Format
Choose your orderVolume discount applies automatically

Delivery terms are confirmed before payment

Da Nang: about 30 minutes · every other Vietnam address: 1–2 days

Retatrutide reconstitution calculator

  • Labeled vial
  • Swabs + syringe
  • Written confirmation
Order

Store reviews

Research use only

Retatrutide 10 mg / 20 mg research vial 01
Explore the molecule

RetatrutideThree receptor pathways in one molecule

A clear starting point. Follow the research, unpack the terminology and compare related profiles.

Formats and prices
The story behind the name

What is Retatrutide?

Retatrutide brings GLP-1, GIP and glucagon receptor activity into one molecule. Researchers investigate how these pathways interact in appetite, energy expenditure and weight regulation, giving it a distinct profile alongside single- and dual-receptor compounds.

Research questions

What do researchers investigate?

Triple receptor agonism (GLP-1 / GIP / glucagon)

Energy expenditure and metabolic signalling

Comparative research against dual-agonist peptides

Unpack the terminology

Tap a term to see what it means.

Receptor

A protein that recognises a signal. Studying receptor binding helps explain which cellular pathway a molecule may engage.

Agonist

A molecule that activates a receptor. The receptor target and the experimental setting both matter when interpreting a result.

Compare

Put the profiles side by side

Compare research directions and labelled formats. Choose a related material to explore the difference.

This material

Retatrutide

Retatrutide
Three receptor pathways in one molecule

Three metabolic targets, one peptide: GLP-1, GIP and glucagon in weight-regulation research.

Listed formats10 mg · 15 mg · 20 mg
Related profile

Tirzepatide

Tirzepatide
A dual signal: GIP and GLP-1

Appetite and glucose balance: a dual GLP-1/GIP peptide at the heart of metabolic research.

Listed formats15 mg · 20 mg · 30 mg
Explore this profile
Questions

A closer look at the details

What is Retatrutide?

A synthetic investigational peptide that activates the GLP-1, GIP and glucagon receptors simultaneously. It was developed by Eli Lilly and remains in clinical trials, it is not an approved medicine. Listed here as a non-clinical research material only.

How is Retatrutide different from Tirzepatide?

Tirzepatide is a dual agonist: it targets GLP-1 and GIP. Retatrutide adds a third target, the glucagon receptor. That extra arm is the main reason the two are compared in metabolic research.

What does the amount on the label mean?

The label records the amount or volume in the vial. It identifies the format; it does not define a use regimen.

Research context, not a promise of clinical effects. Read each study in its original experimental setting.

Format and price

Available options.

FAQ

Retatrutide

What is Retatrutide?

A synthetic investigational peptide that activates the GLP-1, GIP and glucagon receptors simultaneously. It was developed by Eli Lilly and remains in clinical trials, it is not an approved medicine. Listed here as a non-clinical research material only.

How is Retatrutide different from Tirzepatide?

Tirzepatide is a dual agonist: it targets GLP-1 and GIP. Retatrutide adds a third target, the glucagon receptor. That extra arm is the main reason the two are compared in metabolic research.

How do I check Retatrutide availability?

Tap “Order” and choose WhatsApp or Telegram. Your chosen app opens a short message with Retatrutide 10 mg / 20 mg. Send it to check availability.

Can I pay directly on the website?

No. After confirmation, payment is accepted in VND or USD.